These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epigenetic regulation of somatic cell reprogramming. Wang Y; Bi Y; Gao S Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984 [TBL] [Abstract][Full Text] [Related]
4. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation. Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336 [No Abstract] [Full Text] [Related]
5. The genomic stability of induced pluripotent stem cells. Chen Z; Zhao T; Xu Y Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751 [TBL] [Abstract][Full Text] [Related]
6. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells. Brix J; Zhou Y; Luo Y J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984 [TBL] [Abstract][Full Text] [Related]
7. Genomic Instability of iPSCs and Challenges in Their Clinical Applications. Yoshihara M; Oguchi A; Murakawa Y Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780 [TBL] [Abstract][Full Text] [Related]
14. iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter? Scesa G; Adami R; Bottai D Cells; 2021 Jun; 10(6):. PubMed ID: 34208270 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic and Transcriptional Shifts in Human Neural Stem Cells after Reprogramming into Induced Pluripotent Stem Cells and Subsequent Redifferentiation. Haubenreich C; Lenz M; Schuppert A; Peitz M; Koch P; Zenke M; Brüstle O Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542188 [TBL] [Abstract][Full Text] [Related]
16. Cancer cells as a new source of induced pluripotent stem cells. Shamsian A; Sahebnasagh R; Norouzy A; Hussein SH; Ghahremani MH; Azizi Z Stem Cell Res Ther; 2022 Sep; 13(1):459. PubMed ID: 36064437 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933 [TBL] [Abstract][Full Text] [Related]
18. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape. Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562 [TBL] [Abstract][Full Text] [Related]
19. Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy. Li Y; Darabi R J Cell Biochem; 2022 Feb; 123(2):147-154. PubMed ID: 34668236 [TBL] [Abstract][Full Text] [Related]